Bischof & Partner Partnerschaftsge Sellschaft Oliver Bischof competitive analysis

Explore patent oppositions filed by Bischof & Partner Partnerschaftsge Sellschaft Oliver Bischof against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 6, 2026
Patent NumberTitleApplicantOpposition Date
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 2, 2026
Single-Use Cell Culture Container With One Or More In-Situ Online SensorsF HOFFMANN LA ROCHEApr 2, 2025

Latest PTAB cases involving Bischof & Partner Partnerschaftsge Sellschaft Oliver Bischof

Discover the latest PTAB cases involving Bischof & Partner Partnerschaftsge Sellschaft Oliver Bischof, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Bischof & Partner Partnerschaftsge Sellschaft Oliver Bischof with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 6, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BISCHOF & PARTNER PARTNERSCHAFTSGE SELLSCHAFT OLIVER BISCHOF2 - - -
BAYER HEALTHCARE - 21 - 1
F HOFFMANN LA ROCHE16195 - -
REGENERON PHARMACEUTICALS38120932